A Review of Web-Based Tools for Value-of-Information Analysis.
Journal
Applied health economics and health policy
ISSN: 1179-1896
Titre abrégé: Appl Health Econ Health Policy
Pays: New Zealand
ID NLM: 101150314
Informations de publication
Date de publication:
09 2021
09 2021
Historique:
accepted:
11
05
2021
pubmed:
29
5
2021
medline:
26
11
2021
entrez:
28
5
2021
Statut:
ppublish
Résumé
Value-of-information analysis (VOI) is a decision-theoretic approach that is used to inform reimbursement decisions, optimise trial design and set research priorities. The application of VOI analysis for informing policy decisions in practice has been limited due, in part, to the perceived complexity associated with the calculation of VOI measures. Recent efforts have resulted in the development of efficient methods to estimate VOI measures and the development of user-friendly web-based tools to facilitate VOI calculations. We review the existing web-based tools including Sheffield Accelerated Value of Information (SAVI), the web interface to the BCEA (Bayesian Cost-Effectiveness Analysis) R package (BCEAweb), Rapid Assessment of Need for Evidence (RANE), and Value of Information for Cardiovascular Trials and Other Comparative Research (VICTOR). We describe what each tool is designed to do, the inputs they require, and the outputs they produce. Finally, we discuss how tools for VOI calculations might be improved in the future to facilitate the use of VOI analysis in practice.
Identifiants
pubmed: 34046866
doi: 10.1007/s40258-021-00662-4
pii: 10.1007/s40258-021-00662-4
pmc: PMC7613968
mid: EMS158428
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
645-651Subventions
Organisme : Medical Research Council
ID : G0601721
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00002/11
Pays : United Kingdom
Organisme : National Health and Medical Research Council
ID : GNT1121232
Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Value Health. 2020 Mar;23(3):277-286
pubmed: 32197720
Pharmacoeconomics. 2017 Dec;35(12):1287-1296
pubmed: 28849538
Pharmacoeconomics. 2018 May;36(5):555-565
pubmed: 29478116
Pharmacoeconomics. 2013 Jan;31(1):25-48
pubmed: 23329591
Appl Health Econ Health Policy. 2019 Dec;17(6):761-770
pubmed: 31257553
Med Decis Making. 2020 Apr;40(3):314-326
pubmed: 32297840
Med Decis Making. 2015 Jul;35(5):570-83
pubmed: 25810269
Value Health. 2020 Feb;23(2):139-150
pubmed: 32113617
Am Heart J. 2019 Mar;209:116-125
pubmed: 30638543
Value Health. 2018 Feb;21(2):203-209
pubmed: 29477402
Pharmacoeconomics. 2015 Feb;33(2):105-21
pubmed: 25336432
Expert Rev Pharmacoecon Outcomes Res. 2015;15(5):745-54
pubmed: 26400219
Pharmacoeconomics. 2017 Oct;35(10):1063-1072
pubmed: 28695544
Med Decis Making. 2018 May;38(4):427-438
pubmed: 29529923
Value Health. 2015 Sep;18(6):865-75
pubmed: 26409615
BMJ Glob Health. 2020 Aug;5(8):
pubmed: 32868268
MDM Policy Pract. 2016 Jul 07;1(1):2381468316642238
pubmed: 30288400
Value Health. 2020 Jun;23(6):734-742
pubmed: 32540231
Appl Health Econ Health Policy. 2015 Apr;13(2):167-79
pubmed: 25650349
BMJ. 2015 Nov 25;351:h5987
pubmed: 26608737
J Med Econ. 2014 Jun;17(6):377-83
pubmed: 24650041
Clin Trials. 2014 Dec;11(6):648-56
pubmed: 25084784
Med Decis Making. 2011 Nov-Dec;31(6):E1-E22
pubmed: 21712493
BMJ Open. 2018 Dec 22;8(12):e026207
pubmed: 30580278
Med Decis Making. 2014 Apr;34(3):311-26
pubmed: 24246566